business

JENECELL’s comprehensive regenerative platform
drives the creation of new value in regenerative medicine.

Strategic Partnerships

JENECELL builds trust-based partnerships
to drive global innovation in biotechnology.

Identifying Promising
Korean Biotech Companies

  • JENECELL continuously seeks out companies with strong technological capabilities and high growth potential within Korea’s biotechnology ecosystem.
  • Through audits and joint evaluations, JENECELL identifies opportunities for synergy in areas such as stem cell technology, regenerative medicine, and biotech ingredients.
  • By forming partnerships that span from early-stage development to commercialization, JENECELL works to advance innovation and strengthen the Korean biotechnology industry.

Business Alliances
and M&As

  • Shared growth with partners is achieved through strategic alliances focused on technological collaboration and joint R&D.
  • Strategic alliances and M&A are leveraged to strengthen core competencies and accelerate competitiveness in the global market.
  • Long-term partnerships are fostered through transparent and specialized evaluation processes.

A Global Network
for Innovation

  • Through collaboration with Alfresa and Korean biotech companies, JENECELL sustains its technological edge and expands business opportunities in the global market.
  • R&D aligned with global standards is conducted through networks of research institutes, universities, and clinical partners around the world.
  • Biotech resources from key countries are leveraged to support technology exchange, market expansion, and international collaborative projects.